Taiwan's AP Biosciences and LuminX develops novel cancer treatments

Taiwan's AP Biosciences and LuminX are accelerating the development of drugs and therapies for innovative cancer treatme...

December 1, 2020 | Tuesday | News
Singapore selectively targets pathogenic bacteria using lysins

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

December 1, 2020 | Tuesday | News
Taiwan announces breakthrough in AML treatment

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announces that its new drug Antroquinonol (HO...

November 27, 2020 | Friday | News
Korea develops technology to reverse skin cell aging

Amorepacific R&D Center, together with the Korea Advanced Institute of Science & Technology (KAIST), developed a...

November 27, 2020 | Friday | News
Israel discovers antibody combo to fight COVID-19

Researchers at the Laboratory of Human Antibody Research at Tel Aviv University’s Sackler Faculty of Medicine have...

November 26, 2020 | Thursday | News
Pfizer, LianBio collaborate to bring novel therapeutics in Greater China

US-based Pfizer, Inc. and Shanghai-based LianBio have recently announced that they have entered into a collaboration aim...

November 20, 2020 | Friday | News
AUM, Newsoara Biopharma to co-develop next-gen cancer therapeutics

AUM Biosciences (AUM), a global, clinical-stage healthcare company based in Singapore, focused on discovering, acquiring...

November 20, 2020 | Friday | News
Taiwan discovers new gastric cancer biomarkers for tailored therapy

A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua U...

November 17, 2020 | Tuesday | News
Singapore reveals novel method for cancer treatment

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singa...

November 16, 2020 | Monday | News
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...

November 9, 2020 | Monday | News
Celltrion's anti-COVID-19 monoclonal antibody treatment candidate looks promising

Korea's Celltrion Group on 5 Nov 2020 announced results from the ongoing Phase I clinical trial of CT-P59, an anti-COVID...

November 9, 2020 | Monday | News
Singapore's single-cell precision medicine company 'Proteona' wins Start-up award

Singapore single cell precision medicine company Proteona has been selected as one of the ten winners of Falling Walls B...

November 9, 2020 | Monday | News
Taiwan accelerates pace of gene-editing technologies into clinical settings

In research endeavors to find a cure for many diseases, CRISPR/Cas9 has becoming a precise tool to modify the DNA in mic...

November 6, 2020 | Friday | News
Australia designs model to link heart disease with T2D

Researchers from Australia's University of Sydney’s School of Project Management within the Faculty...

November 4, 2020 | Wednesday | News
Avatamed, Macrogen focus on personalized precision medicine services in cancer treatment

AVATAMED, a precision medicine service company based in Singapore, represented by CEO Hong Boon Toh, has enter...

November 4, 2020 | Wednesday | News
SK Biopharma and LifeSci Venture Partners to push open innovation

SK Biopharmaceuticals, a global innovative pharmaceutical company based in South Korea, has announced that the company h...

November 4, 2020 | Wednesday | News
PerkinElmer to acquire Horizon Discovery for $383M

PerkinElmer, Inc. and Horizon Discovery Group plc have announced that they have reached an agreement on t...

November 2, 2020 | Monday | News
Ocumension strengthens pipeline for posterior segment eye diseases in China

Hong Kong's Ocumension Therapeutics announced that the Company has entered into a collaboration and exclusive ...

October 30, 2020 | Friday | News